The Susan F. Smith Center for Women's Cancers at Dana-Farber Brigham Cancer Center offers several programs for breast cancer patients with unique needs. As a patient, you can be assured of our physicians' expertise and compassion. In addition, you will have access to the breadth of services that an academic medical center and a world-renowned cancer hospital and research center can provide.
Women in their early 40s and younger with breast cancer face particular challenges that require specialized resources. Led by Ann Partridge, MD, MPH, our Young and Strong Program for Young Women with Breast Cancer combines treatment, support services and research and is one of the few programs in the country designed to meet the needs of young women faced with a breast cancer diagnosis.
Treating patients with metastatic breast cancer (MBC) is a significant part of our practice. Our doctors, nurses, social workers, research staff and others provide continuous care, support and assistance. We are committed to providing each patient with the best and most personalized treatment options that are available.
When abnormal cells stay inside the milk ducts and do not spread to nearby tissue, the condition is ductal carcinoma in situ (DCIS), also known as intraductal carcinoma or pre-invasive breast cancer. DCIS is the earliest stage of breast cancer, stage 0 breast cancer. DCIS does not spread to the lymph nodes or metastasize (meaning it doesn't spread to other parts of the body).
The Ductal Carcinoma in Situ program at Dana-Farber Brigham Cancer Center offers specialized care and resources for people diagnosed with this earliest form of breast cancer. This program, the only of its kind in New England, combines patient care with in-depth research and educational resources to provide personalized care for each patient's unique needs. The comprehensive care team from both Brigham and Women's Hospital and Dana-Farber Cancer Institute, includes breast cancer surgeons, medical oncologists and radiation oncologists, as well as dedicated physician assistants and nurse practitioners.
If you or your doctor think that you are at high risk of developing breast or ovarian cancer, the Cancer Genetics and Prevention Program, led by Judy Garber, MD, MPH, will create a personalized program to estimate your risk as accurately as possible and work with you and your clinical team to lower your risk as much as possible. This program works closely with the Breast Cancer Personalized Risk Assessment, Education and Prevention (B-PREP) Program.
A team of experts specializes in treating inflammatory breast cancer (IBC). Dana-Farber Brigham Cancer Center hosts the only program in the Northeast focused solely on this rare but aggressive form of breast cancer.
Each year one in 3,000 women in the United States will be diagnosed with breast cancer during pregnancy. Our clinicians at the Breast Cancer during Pregnancy Program, led by Erica Mayer, MD, MPH, are leaders in achieving healthy outcomes for pregnant women with breast cancer and their babies. The team includes some of the most experienced and respected breast cancer oncologists and maternal-fetal specialists in the world.
Though breast cancer is often considered a disease that affects only women, men can also be diagnosed with breast cancer. Our Male Breast Cancer Program is dedicated to the unique needs of men. Our specialists will work with you to develop a treatment plan that supports your medical and emotional needs.